Heron Therapeutics

HRTXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$56.766 M

$0.30 +10.74%

Close of 22 Sept 2026

Revenue

—

Not reported

Earnings

-$20.0M

Loss-making

Shares outstanding

189,852,307

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#348Serina TherapeuticsSER$58.7M
#349Impact BiomedicalIBO$56.9M
#350Heron TherapeuticsHRTX$56.8M
#351Edesa BiotechEDSA$55.0M
#352Annovis BioANVS$53.8M

What if Heron Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.2T

$159,249.95

Per share 532,609× higher

Bitcoin $1.74T

$9,173.74

Per share 30,681× higher

Nvidia $5.52T

$29,052.94

Per share 97,167× higher

Or at a round number

$100.0M $200.0M $500.0M $1.00B

Where these numbers come from

Share counts and financials for Heron Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.